Phase 1 Polymyositis Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease

Systemic Lupus ErythematosusDermatomyositisPolymyositis+1 more

Miltenyi Biomedicine GmbH24 enrolled1 locationNCT06347718

Recruiting

Phase 1Phase 2

Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

DermatomyositisPolymyositisANCA-associated Vasculitis+2 more

Fondazione Policlinico Universitario Agostino Gemelli IRCCS8 enrolled1 locationNCT06685042